Study S001257

Liraglutide in Type 1 Diabetes

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record Study Protocol and Statistical Analysis Plan (PDF)

Registration

Registration: NCT01722240
Acronym: 1966
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: TRIPLE
Status: COMPLETED
Enrollment: 69
Start: 2012-11-01
Primary completion: 2019-01-01
Lead sponsor: University at Buffalo
Conditions: Type 1 Diabetes
Interventions: DRUG:Liraglutide 1.8mg; DRUG:Placebo
Results posted: TRUE
Secondary identifiers: NIH:1R01DK092653-01A1

Registered primary outcomes

HbA1c (%) [52 Weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.